FDA approves Spravato as first stand-along nasal spray to treat drug-resistant depression
In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.
腾讯网1 天
FDA批准强生(JNJ.US)Spravato(esketamine)鼻喷雾剂用以治疗难治性抑郁症(TRD ...
智通财经APP获悉，强生(JNJ.US)1月21日宣布，美国FDA已批准其Spravato(esketamine)鼻喷雾剂用以治疗难治性抑郁症(TRD)成人患者。试验结果显示，Spravato在第4周时达到主要终点。并且与安慰剂相比，早在24小时内就 ...
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Health and Me on MSN12 小时
FDA Approves ‘Spravato’ Nasal Spray As A Standalone Depression Treatment
We have made great strides in the medical community, with people having access to life-saving physical drugs as well as ...
FDA批准SPRAVATO作为首个单一治疗MDD的药物
新泽西州蒂图斯维尔 - 强生公司（NYSE:JNJ）已获得美国食品和药物管理局（FDA）批准，将SPRAVATO®（艾氯胺酮）鼻喷剂作为单一治疗方案，用于治疗至少两种不同口服抗抑郁药物治疗效果不佳的成年重度抑郁障碍（MDD）患者。这标志着首次有治疗方案被批准作为MDD的单一疗法。
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
HealthDay on MSN15 小时
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...
What is Spravato, an FDA-approved First Standalone Esketamine-based Nasal Spray Monotherapy ...
The US Food and Drug Administration has approved a new nasal spray for depression treatment. Known as Spravato and ...
FDA批准强生(JNJ.US)Spravato鼻喷雾剂用以治疗难治性抑郁症(TRD)成人患者
强生 (JNJ.US)1月21日宣布，美国FDA已批准其Spravato (esketamine)鼻喷雾剂用以治疗难治性抑郁症 (TRD)成人患者。试验结果显示，Spravato在第4周时达到主要终点。并且与安慰剂相比，早在24小时内就可迅速且显著地改善患者的抑郁症状。根据新闻稿，Spravato是获批用以治疗至少对两种口服抗抑郁药应答不佳的成人抑郁症 (MDD)患者的首款单药疗法。
Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
Healio1 天
FDA approves Spravato as monotherapy for adults with major depressive disorder
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...